122 related articles for article (PubMed ID: 15552590)
1. The fate of perfluoro-tagged metabolites of L-DOPA in mice brains.
Dingman S; Mack D; Branch S; Thomas R; Guo C; Branch C
J Immunoassay Immunochem; 2004; 25(4):359-70. PubMed ID: 15552590
[TBL] [Abstract][Full Text] [Related]
2. Enzymatic assay for perfluoro-tagged metabolites of l-DOPA using crude lysate from E. coli transformed with pKKAADCII.
Dingman S; Snyder-Leiby T; Mack DJ; Thomas R; Guo C
Appl Microbiol Biotechnol; 2004 May; 64(4):556-9. PubMed ID: 14634798
[TBL] [Abstract][Full Text] [Related]
3. Aromatic L-amino acid decarboxylase immunoreactive cells in the rat striatum: a possible site for the conversion of exogenous L-DOPA to dopamine.
Mura A; Jackson D; Manley MS; Young SJ; Groves PM
Brain Res; 1995 Dec; 704(1):51-60. PubMed ID: 8750961
[TBL] [Abstract][Full Text] [Related]
4. Dopa decarboxylase activity of the living human brain.
Gjedde A; Reith J; Dyve S; Léger G; Guttman M; Diksic M; Evans A; Kuwabara H
Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2721-5. PubMed ID: 1688340
[TBL] [Abstract][Full Text] [Related]
5. An enzymatic assay for metabolites of perfluoro-tagged 5-hydroxytryptophan.
Snyder-Leiby T; Dingman S; Thomas R; Guo C
Appl Microbiol Biotechnol; 2004 Apr; 64(2):223-7. PubMed ID: 14963615
[TBL] [Abstract][Full Text] [Related]
6. DopAmide: Novel, Water-Soluble, Slow-Release l-dihydroxyphenylalanine (l-DOPA) Precursor Moderates l-DOPA Conversion to Dopamine and Generates a Sustained Level of Dopamine at Dopaminergic Neurons.
Atlas D
CNS Neurosci Ther; 2016 Jun; 22(6):461-7. PubMed ID: 26861609
[TBL] [Abstract][Full Text] [Related]
7. Increase of catecholamines in mouse brain by systemic administration of gamma-glutamyl L-3,4-dihydroxyphenylalanine.
Ichinose H; Togari A; Suzuki H; Kumagai H; Nagatsu T
J Neurochem; 1987 Sep; 49(3):928-32. PubMed ID: 3112308
[TBL] [Abstract][Full Text] [Related]
8. Transmitter-like basal and K(+)-evoked release of 3,4-dihydroxyphenylalanine from the striatum in conscious rats studied by microdialysis.
Nakamura S; Goshima Y; Yue JL; Misu Y
J Neurochem; 1992 Jan; 58(1):270-5. PubMed ID: 1345766
[TBL] [Abstract][Full Text] [Related]
9. The central aromatic amino acid DOPA decarboxylase inhibitor, NSD-1015, does not inhibit L-DOPA-induced circling in unilateral 6-OHDA-lesioned-rats.
Treseder SA; Rose S; Jenner P
Eur J Neurosci; 2001 Jan; 13(1):162-70. PubMed ID: 11135014
[TBL] [Abstract][Full Text] [Related]
10. Neurons expressing individual enzymes of dopamine synthesis in the mediobasal hypothalamus of adult rats: functional significance and topographic interrelations.
Ugrumov M; Taxi J; Pronina T; Kurina A; Sorokin A; Sapronova A; Calas A
Neuroscience; 2014 Sep; 277():45-54. PubMed ID: 24997271
[TBL] [Abstract][Full Text] [Related]
11. Dopamine synthesis by non-dopaminergic neurons expressing individual complementary enzymes of the dopamine synthetic pathway in the arcuate nucleus of fetal rats.
Ugrumov MV; Melnikova VI; Lavrentyeva AV; Kudrin VS; Rayevsky KS
Neuroscience; 2004; 124(3):629-35. PubMed ID: 14980733
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of in vitro decarboxylation and the in vivo metabolism of 2-18F- and 6-18F-fluorodopa in the hooded rat.
Cumming P; Häusser M; Martin WR; Grierson J; Adam MJ; Ruth TJ; McGeer EG
Biochem Pharmacol; 1988 Jan; 37(2):247-50. PubMed ID: 3124856
[TBL] [Abstract][Full Text] [Related]
13. BIA 3-202, a novel catechol-O-methyltransferase inhibitor, enhances the availability of L-DOPA to the brain and reduces its O-methylation.
Parada A; Loureiro AI; Vieira-Coelho MA; Hainzl D; Soares-da-Silva P
Eur J Pharmacol; 2001 May; 420(1):27-32. PubMed ID: 11412836
[TBL] [Abstract][Full Text] [Related]
14. Effect of hypoxia/hypercapnia on metabolism of 6-[(18)F]fluoro-L-DOPA in newborn piglets.
Bauer R; Brust P; Walter B; Vorwieger G; Bergmann R; Elhalag E; Fritz A; Steinbach J; Füchtner F; Hinz R; Zwiener U; Johannsen B
Brain Res; 2002 Apr; 934(1):23-33. PubMed ID: 11937066
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of an 18F-labeled dopa prodrug as a PET tracer for studying brain dopamine metabolism.
Ishiwata K; Shinoda M; Ishii S; Nozaki T; Senda M
Nucl Med Biol; 1996 Apr; 23(3):295-301. PubMed ID: 8782240
[TBL] [Abstract][Full Text] [Related]
16. Radiofluorinated L-m-tyrosines: new in-vivo probes for central dopamine biochemistry.
Barrio JR; Huang SC; Yu DC; Melega WP; Quintana J; Cherry SR; Jacobson A; Namavari M; Satyamurthy N; Phelps ME
J Cereb Blood Flow Metab; 1996 Jul; 16(4):667-78. PubMed ID: 8964807
[TBL] [Abstract][Full Text] [Related]
17. 3,4-Dihydroxyphenylethylamine, L-3,4-dihydroxyphenylalanine and 3,4,5-trihydroxyphenylalanine: oxidation and binding to membranes. A comparative study of a neurotransmitter, a precursor and a neurotransmitter candidate in primitive nervous systems.
Carlberg M
J Neural Transm Gen Sect; 1990; 81(2):111-9. PubMed ID: 1973046
[TBL] [Abstract][Full Text] [Related]
18. Fluorodopa is a Promising Fluorine-19 MRI Probe for Evaluating Striatal Dopaminergic Function in a Rat Model of Parkinson's Disease.
Yanagisawa D; Oda K; Inden M; Morikawa S; Inubushi T; Taniguchi T; Hijioka M; Kitamura Y; Tooyama I
J Neurosci Res; 2017 Jul; 95(7):1485-1494. PubMed ID: 27792255
[TBL] [Abstract][Full Text] [Related]
19. Nicotinic acid or N-methyl nicotinamide prolongs elevated brain dopa and dopamine in L-dopa treatment.
Black MJ; Brandt RB
Biochem Med Metab Biol; 1986 Oct; 36(2):244-51. PubMed ID: 2946308
[TBL] [Abstract][Full Text] [Related]
20. Conjugates of catecholamines with cysteine and GSH in Parkinson's disease: possible mechanisms of formation involving reactive oxygen species.
Spencer JP; Jenner P; Daniel SE; Lees AJ; Marsden DC; Halliwell B
J Neurochem; 1998 Nov; 71(5):2112-22. PubMed ID: 9798937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
